DERMATLANTA.COM > ABOUT DERMATOLOGY ASSOCIATES OF ATLANTA > JOSEPH R. PAYNE, MD
Joseph R. Payne, MD
Curriculum Vitae
Georgia: 059889 (expires 6/30/2009)
Florida: ME 91573 (expires 1/31/2009)
Virginia: 0101235751 (expires 6/30/2006)
Certification:
Specialty: Dermatology
Certifying Board: American Board of Dermatology
Date Certified: August 2004 (expires 2014)
Hospital Privileges:
Northside Hospital Atlanta, GA (pending)
St. Joseph’s Hospital Atlanta, GA (pending)
Undergraduate Education:
Georgia Institute of Technology
Atlanta, Georgia
Bachelors of Mechanical Engineering with Highest Honor
September 1990 – March 1996
Medical Education:
Duke University School of Medicine
Durham, North Carolina
Doctorate of Medicine
August 1996 – May 2000
Internship:
Duke University Hospital
Durham, North Carolina
Department of Internal Medicine
June 2000 – June 2001
Residency:
The George Washington University Hospital
Washington, District of Columbia
Department of Dermatology
July 2001 – July 2004
Military Service:
United States Navy
November 28, 2001 to present
Current Rank: Lieutenant Commander
Professional Experience:
August, 2007 to present Staff Dermatologist
Dermatology Associates of Atlanta, P.C.
5555 Peachtree-Dunwoody Road
Suite 190
Atlanta, GA 30342
January, 2005 to January, 2008 Staff Dermatologist
North Florida Dermatology Associates, P.A.
1551 Riverside Avenue
Jacksonville, FL 32204
August, 2004 to February, 2008 Department Head of Dermatology
Naval Hospital Jacksonville
2080 Child Street
Jacksonville, FL 32214-5000
Memberships:
Diplomate, American Board of Dermatology
Fellow, American Academy of Dermatology
Member, American Society for Dermatologic Surgery
Fellow, American Society for Mohs Surgery
Clinical Research Trials and Publications:
“A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis,” Abbott, 2007.
“A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled Study Comparing 1% Clindamycin/ 5% Benzoyl Peroxide Topical Gel (KV Pharmaceutical Company) to DUAC Topical Gel 1% Clindamycin/ 5% Benzoyl Peroxide (Stiefel) in the Treatment of Moderate to Severe Acne Vulgaris,” KV Pharmaceutical Company, 2007.
“A Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Clinical Equivalence of Generic Metronidazole Gel 1% (TOLMAR Inc.) to METROGEL (metronidazole gel) 1% (Galderma Laboratories, LP) and both Active Treatments to a Vehicle Control in the Treatment of Inflammatory Rosacea Lesions,” TOLMAR Inc., 2007.
“A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Evaluate the Bioequivalence of Calcipotriene Ointment 0.005% (Glenmark Pharmaceuticals) to DOVONEX (calcipotriene ointment) 0.005% (Bristol Meyer Squibb) in patients with Moderate to Severe Plaque Psoriasis,” Glenmark Pharmaceuticals, Inc., 2007.
“A Randomized, Double-Blind, Multiple-Site, Placebo Controlled Study Comparing 1% Clindamycin/ 5% Benzoyl Peroxide Topical Gel (KV Pharmaceutical Company) to Benzaclin Topical Gel 1% Clindamycin/ 5% Benzoyl Peroxide (Dermik) in the Treatment of Moderate to Severe Acne Vulgaris,” KV Pharmaceutical Company, 2007.
“An Open Label, Multi-center, Uncontrolled, Single Group Assessment, Long Term Safety Study of 4% Tradename (Fluorouracil) Cream in Subjects with Actinic Keratosis,” HILL Dermaceuticals, Inc., 2007.
“A Phase III, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 4-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of Clindaben (1/2.5), Clindaben Vehicle, Clindamycin (1%), and Benzoyl Peroxide (2.5%) Gels in the Treatment of Moderate to Severe Acne Vulgaris,” Dow Pharmaceutical Sciences, Inc., 2007.
Marjan Yousefi, MD, Joseph R. Payne, MD, and Raymond Barnhill, MD (March 2006). Alopecia areata associated with regression of cutaneous melanoma. International Journal of Dermatology, 45 (3), 314-315.
“Patients Using MICRO Properly; An Open Label, Community Based, Phase Four Study to Assess Facial Acne Improvement with Use of RETIN-A MICRO® (Tretinoin Gel) Microsphere, 0.04% or 0.1% in a Pump Dispenser,” Johnson & Johnson CPW, 2006.
Clinical Research Trials and Publications (cont):
“Observational Post-Marketing Safety Surveillance Registry of Enbrel® (Etanercept) for the Treatment of Psoriasis,” Amgen, Inc., 2006.
“Clobex® Spray Community based Research Assessment (COBRA) Trial,” Galderma Laboratories, LP, 2006.
“A Randomized, Evaluator Blinded, Vehicle-Controlled Multi-Center Study of the Safety and Efficacy of 4% TRADENAME (Fluorouracil) Cream Versus Its Vehicle Versus Efudex® Cream in the Treatment of Actinic Keratosis,” Hill Dermaceuticals, Inc., 2006.
“Assessment and Tracking of Long-Term Alefacept Safety (ATLAS),” Biogen Idec, 2005.
“A Phase 3, Long-Term, Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis,” Astellas Pharma, Inc., 2005.
“A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis (APPLES),” Astellas Pharma, Inc., 2005.
“KFD.C.005, A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of Ketaconazole Foam, 2%, versus Teva® (ketaconazole) 2% Cream in the Treatment of Seborrheic Dermatitis,” Connetics Corporation, 2005.
“Raptiva® Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients with Chronic Moderate to Severe Plaque Psoriasis (RESPONSE),” Genentech, 2005.
American Academy of Dermatology Summer Academy Meeting, New York, NY, July 31-August 4, 2002
American Academy of Dermatology 61st Annual Meeting, San Francisco, CA, March 21-25, 2003
Orlando Cosmetic Dermatology Convention, Orlando, FL, January 8-11, 2004
American Academy of Dermatology 62nd Annual Meeting, Washington, DC, February 6-
11, 2004
National Naval Medical Center and Walter Reed Army Medical Center – Washington, DC Dermatological Society Clinical Conference, Washington, DC, March 23, 2004
Dave Barron Dermatopathology Seminar, Cincinnati, OH, April 15-16, 2004
American Academy of Dermatology 63rd Annual Meeting, New Orleans, LA, February 18-21, 2005
Uniformed Services Dermatology Seminar, Washington, DC, May 31-June 4, 2005
American Society for Mohs Surgery: Fundamentals of Mohs Surgery, San Diego, CA, November 10-13, 2005
American Academy of Dermatology 64th Annual Meeting, San Francisco, CA, March 3-7, 2006
American Society for Dermatologic Surgery Annual Meeting, Palm Desert, CA, October 26-28, 2006
American Academy of Dermatology 65th Annual Meeting, Washington, DC, February 2-6, 2007
American Society for Mohs Surgery 12th Annual Clinical Symposium, Santa Ana Pueblo, NM, May 25-27, 2007
American Academy of Dermatology 66th Annual Meeting, San Antonio, TX, January 31-February 5, 2008